LPL Financial’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.6M | Buy |
44,772
+940
| +2% | +$527K | 0.01% | 1473 |
|
|
2026
Q1 | $24.6M | Sell |
43,832
-1,804
| -4% | -$1.16M | 0.01% | 1329 |
|
|
2025
Q4 | $30.9M | Buy |
45,636
+5,813
| +15% | +$3.96M | 0.01% | 1125 |
|
|
2025
Q3 | $25.4M | Buy |
39,823
+3,731
| +10% | +$2.26M | 0.01% | 1212 |
|
|
2025
Q2 | $19.4M | Sell |
36,092
-1,408
| -4% | -$673K | 0.01% | 1275 |
|
|
2025
Q1 | $15.7M | Buy |
37,500
+3,963
| +12% | +$1.72M | 0.01% | 1308 |
|
|
2024
Q4 | $13.9M | Sell |
33,537
-9,600
| -22% | -$4.21M | 0.01% | 1310 |
|
|
2024
Q3 | $21.8M | Buy |
43,137
+1,442
| +3% | +$701K | 0.01% | 1004 |
|
|
2024
Q2 | $20.3M | Buy |
41,695
+5,728
| +16% | +$2.88M | 0.01% | 965 |
|
|
2024
Q1 | $19.4M | Buy |
35,967
+2,128
| +6% | +$1.16M | 0.01% | 959 |
|
|
2023
Q4 | $18.8M | Sell |
33,839
-2,804
| -8% | -$1.32M | 0.01% | 912 |
|
|
2023
Q3 | $16M | Buy |
36,643
+11,548
| +46% | +$5.76M | 0.01% | 902 |
|
|
2023
Q2 | $12.6M | Buy |
25,095
+3,634
| +17% | +$1.74M | 0.01% | 1011 |
|
|
2023
Q1 | $10.7M | Buy |
21,461
+453
| +2% | +$217K | 0.01% | 1051 |
|
|
2022
Q4 | $8.57M | Sell |
21,008
-1,712
| -8% | -$665K | 0.01% | 1115 |
|
|
2022
Q3 | $7.4M | Buy |
22,720
+264
| +1% | +$97K | 0.01% | 1116 |
|
|
2022
Q2 | $7.88M | Sell |
22,456
-24,961
| -53% | -$10.2M | 0.01% | 1096 |
|
|
2022
Q1 | $25.9M | Sell |
47,417
-5,759
| -11% | -$3.03M | 0.02% | 568 |
|
|
2021
Q4 | $35M | Buy |
53,176
+3,774
| +8% | +$2.37M | 0.03% | 462 |
|
|
2021
Q3 | $30.7M | Buy |
49,402
+24,639
| +99% | +$16.6M | 0.03% | 468 |
|
|
2021
Q2 | $15.6M | Sell |
24,763
-254
| -1% | -$140K | 0.02% | 687 |
|
|
2021
Q1 | $12.2M | Buy |
25,017
+2,252
| +10% | +$1.13M | 0.01% | 733 |
|
|
2020
Q4 | $11.4M | Buy |
22,765
+9,704
| +74% | +$4.34M | 0.01% | 692 |
|
|
2020
Q3 | $5.13M | Buy |
13,061
+2,170
| +20% | +$802K | 0.01% | 943 |
|
|
2020
Q2 | $3.6M | Sell |
10,891
-2,221
| -17% | -$643K | 0.01% | 1037 |
|
|
2020
Q1 | $3.18M | Buy |
13,112
+178
| +1% | +$46.5K | 0.01% | 939 |
|
|
2019
Q4 | $3.38M | Buy |
12,934
+726
| +6% | +$191K | 0.01% | 1038 |
|
|
2019
Q3 | $3.32M | Sell |
12,208
-1,499
| -11% | -$417K | 0.01% | 970 |
|
|
2019
Q2 | $3.77M | Buy |
13,707
+2,152
| +19% | +$530K | 0.01% | 909 |
|
|
2019
Q1 | $2.58M | Buy |
11,555
+159
| +1% | +$32.8K | 0.01% | 1050 |
|
|
2018
Q4 | $2.12M | Sell |
11,396
-1,012
| -8% | -$207K | 0.01% | 1048 |
|
|
2018
Q3 | $3.1M | Buy |
12,408
+1,702
| +16% | +$413K | 0.01% | 937 |
|
|
2018
Q2 | $2.33M | Sell |
10,706
-848
| -7% | -$175K | 0.01% | 1041 |
|
|
2018
Q1 | $2.21M | Sell |
11,554
-5,519
| -32% | -$1.02M | 0.01% | 1050 |
|
|
2017
Q4 | $2.67M | Sell |
17,073
-741
| -4% | -$117K | 0.01% | 897 |
|
|
2017
Q3 | $2.76M | Buy |
17,814
+1,160
| +7% | +$183K | 0.01% | 834 |
|
|
2017
Q2 | $2.68M | Buy |
16,654
+1,608
| +11% | +$261K | 0.01% | 790 |
|
|
2017
Q1 | $2.34M | Sell |
15,046
-703
| -4% | -$96.9K | 0.02% | 750 |
|
|
2016
Q4 | $1.85M | Sell |
15,749
-535
| -3% | -$61.1K | 0.01% | 850 |
|
|
2016
Q3 | $1.84M | Sell |
16,284
-15,452
| -49% | -$1.63M | 0.02% | 817 |
|
|
2016
Q2 | $2.97M | Buy |
31,736
+25,661
| +422% | +$2.2M | 0.03% | 563 |
|
|
2016
Q1 | $479K | Sell |
6,075
-107
| -2% | -$7.71K | ﹤0.01% | 2187 |
|
|
2015
Q4 | $448K | Sell |
6,182
-18,312
| -75% | -$1.31M | ﹤0.01% | 2268 |
|
|
2015
Q3 | $1.84M | Buy |
24,494
+14
| +0.1% | +$1K | 0.01% | 879 |
|
|
2015
Q2 | $1.54M | Buy |
24,480
+3,596
| +17% | +$249K | 0.01% | 1076 |
|
|
2015
Q1 | $1.58M | Buy |
20,884
+7,502
| +56% | +$584K | 0.01% | 1042 |
|
|
2014
Q4 | $992K | Buy |
13,382
+6,148
| +85% | +$431K | 0.01% | 1313 |
|
|
2014
Q3 | $438K | Sell |
7,234
-36
| -0.5% | -$2.28K | ﹤0.01% | 1890 |
|
|
2014
Q2 | $486K | Buy |
+7,270
| New | +$462K | ﹤0.01% | 1825 |
|
Other funds holding IDXX
MBI
CGI
LPL Financial's IDXX Position: Q2 2026 in Review
LPL Financial increased its Idexx Laboratories (IDXX) stake by 2.1% in Q2 2026, buying an estimated $527K and bringing the position to 44,772 shares worth $23.6M. The position accounts for 0.01% of the portfolio, ranked #1473.
LPL Financial first reported a position in IDXX in Q2 2014 and has held it in 49 quarters since. The position peaked at $35M in Q4 2021. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- LPL Financial held 44,772 shares of Idexx Laboratories worth $23.6M as of Q2 2026.
- LPL Financial bought 940 Idexx Laboratories shares in Q2 2026, an estimated $527K.
- Idexx Laboratories made up 0.01% of LPL Financial's portfolio in Q2 2026, its #1473 holding.
- LPL Financial first reported a position in Idexx Laboratories in Q2 2014 and has held it in 49 quarters since.
- LPL Financial's Idexx Laboratories position peaked at $35M in Q4 2021.
- 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.